Glimepiride Clinical Trials Glimepiride RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin
Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: ITCA 650 20/60 mcg/day;   Drug: Empagliflozin (oral);   Drug: Glimepiride (oral) Sponsor:   Intarcia Therapeutics Not yet recruiting - verified February 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2017 Category: Research Source Type: clinical trials

Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin
Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: ITCA 650 20/60 mcg/day;   Drug: Empagliflozin (oral);   Drug: Glimepiride (oral) Sponsor:   Intarcia Therapeutics Recruiting - verified March 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2017 Category: Research Source Type: clinical trials

Teneligliptin-Glimepiride DDI Study
Condition:   Diabetes Mellitus Intervention:   Drug: Teneligliptin+Glimepiride Sponsor:   Handok Pharmaceuticals Co., Ltd. Not yet recruiting - verified December 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 28, 2016 Category: Research Source Type: clinical trials